These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 25463093)

  • 21. Comparison of atorvastatin, pitavastatin and rosuvastatin for residual cardiovascular risk using non-fasting blood sampling.
    Kakuda H; Matoba M; Nakatoh H; Nagao S; Takekoshi N
    Scand J Clin Lab Invest; 2014 Jun; 74(4):285-95. PubMed ID: 24564634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monocyte and macrophage subtypes as paired cell biomarkers for coronary artery disease.
    Arnold KA; Blair JE; Paul JD; Shah AP; Nathan S; Alenghat FJ
    Exp Physiol; 2019 Sep; 104(9):1343-1352. PubMed ID: 31264265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic Value of Human Peripheral Monocyte Subsets for Future Coronary Events in Patients Without Significant Coronary Artery Stenosis.
    Kashiwagi M; Imanishi T; Ozaki Y; Taruya A; Nishiguchi T; Katayama Y; Tanimoto T; Kuroi A; Kubo T; Tanaka A; Akasaka T
    Circ J; 2019 Oct; 83(11):2250-2256. PubMed ID: 31511449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monocyte subset distribution is associated with mortality in critically ill patients.
    Krychtiuk KA; Lenz M; Koller L; Honeder MC; Wutzlhofer L; Zhang C; Chi L; Maurer G; Niessner A; Huber K; Wojta J; Heinz G; Speidl WS
    Thromb Haemost; 2016 Oct; 116(5):949-957. PubMed ID: 27604519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LDL-C/HDL-C ratio in subjects with cardiovascular disease and a low HDL-C: results of the RADAR (Rosuvastatin and Atorvastatin in different Dosages And Reverse cholesterol transport) study.
    Jukema JW; Liem AH; Dunselman PH; van der Sloot JA; Lok DJ; Zwinderman AH
    Curr Med Res Opin; 2005 Nov; 21(11):1865-74. PubMed ID: 16307708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Standardized flow cytometry assay for identification of human monocytic heterogeneity and LRP1 expression in monocyte subpopulations: decreased expression of this receptor in nonclassical monocytes.
    Ferrer DG; Jaldín-Fincati JR; Amigone JL; Capra RH; Collino CJ; Albertini RA; Chiabrando GA
    Cytometry A; 2014 Jul; 85(7):601-10. PubMed ID: 24639232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subgroups of monocytes predict cardiovascular events in patients with coronary heart disease. The PHAMOS trial (Prospective Halle Monocytes Study).
    Höpfner F; Jacob M; Ulrich C; Russ M; Simm A; Silber RE; Girndt M; Noutsias M; Werdan K; Schlitt A
    Hellenic J Cardiol; 2019; 60(5):311-321. PubMed ID: 31055050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relation of oxidized-low-density lipoprotein and high-density lipoprotein subfractions in non-treated patients with coronary artery disease.
    Zhao X; Zhang HW; Sun D; Xu RX; Guo YL; Sun J; Zhu CG; Wu NQ; Zhang Y; Li S; Li JJ
    Prostaglandins Other Lipid Mediat; 2019 Oct; 144():106345. PubMed ID: 31278984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heterogeneity of human monocytes: an optimized four-color flow cytometry protocol for analysis of monocyte subsets.
    Tallone T; Turconi G; Soldati G; Pedrazzini G; Moccetti T; Vassalli G
    J Cardiovasc Transl Res; 2011 Apr; 4(2):211-9. PubMed ID: 21308491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation between serum lipid profiles and the ratio and count of the CD16+ monocyte subset in peripheral blood of apparently healthy adults.
    Huang ZS; Chiang BL
    J Formos Med Assoc; 2002 Jan; 101(1):11-7. PubMed ID: 11911032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of inflammatory signaling in monocytes from patients with coronary artery disease.
    Schirmer SH; Fledderus JO; van der Laan AM; van der Pouw-Kraan TC; Moerland PD; Volger OL; Baggen JM; Böhm M; Piek JJ; Horrevoets AJ; van Royen N
    J Mol Cell Cardiol; 2009 Feb; 46(2):177-85. PubMed ID: 19059264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD14+,CD16+ blood monocytes and joint inflammation in rheumatoid arthritis.
    Kawanaka N; Yamamura M; Aita T; Morita Y; Okamoto A; Kawashima M; Iwahashi M; Ueno A; Ohmoto Y; Makino H
    Arthritis Rheum; 2002 Oct; 46(10):2578-86. PubMed ID: 12384915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of monocyte subset counts with coronary fibrous cap thickness in patients with unstable angina pectoris.
    Imanishi T; Ikejima H; Tsujioka H; Kuroi A; Ishibashi K; Komukai K; Tanimoto T; Ino Y; Takeshita T; Akasaka T
    Atherosclerosis; 2010 Oct; 212(2):628-35. PubMed ID: 20615506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Association of Lipoprotein(a) and Circulating Monocyte Subsets with Severe Coronary Atherosclerosis.
    Afanasieva OI; Filatova AY; Arefieva TI; Klesareva EA; Tyurina AV; Radyukhina NV; Ezhov MV; Pokrovsky SN
    J Cardiovasc Dev Dis; 2021 Jun; 8(6):. PubMed ID: 34206012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial.
    Stender S; Schuster H; Barter P; Watkins C; Kallend D;
    Diabetes Obes Metab; 2005 Jul; 7(4):430-8. PubMed ID: 15955130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of atorvastatin on circulating proinflammatory T-lymphocyte subsets and soluble CD40 ligand in patients with stable coronary artery disease--a randomized, placebo-controlled study.
    Alber HF; Frick M; Suessenbacher A; Doerler J; Schirmer M; Stocker EM; Dichtl W; Pachinger O; Weidinger F
    Am Heart J; 2006 Jan; 151(1):139. PubMed ID: 16368305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating CD14
    Meeuwsen JAL; de Vries JJ; van Duijvenvoorde A; van der Velden S; van der Laan SW; van Koeverden ID; van de Weg SM; de Borst GJ; de Winther MPJ; Kuiper J; Pasterkamp G; Hoefer IE; de Jager SCA;
    J Mol Cell Cardiol; 2019 Feb; 127():260-269. PubMed ID: 30629987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of statin therapy withdrawal on monocyte subsets.
    Jaipersad AS; Shantsila E; Blann A; Lip GY
    Eur J Clin Invest; 2013 Dec; 43(12):1307-13. PubMed ID: 24134608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for an exclusive association of matrix metalloproteinase-9 with dysfunctional high-density lipoprotein: a novel finding.
    Sini S; Deepa D; Harikrishnan S; Jayakumari N
    Atherosclerosis; 2014 Sep; 236(1):162-8. PubMed ID: 25055059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of Toll-Like Receptor 4 on Human Monocyte Subsets and Vulnerability Characteristics of Coronary Plaque as Assessed by 64-Slice Multidetector Computed Tomography.
    Ozaki Y; Imanishi T; Hosokawa S; Nishiguchi T; Taruya A; Tanimoto T; Kuroi A; Yamano T; Matsuo Y; Ino Y; Kitabata H; Kubo T; Tanaka A; Akasaka T
    Circ J; 2017 May; 81(6):837-845. PubMed ID: 28344199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.